| Patent | Date |
|---|
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20180280408 - Belvin; Marcia ; et al. | 2018-10-04 |
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
Grant 10,004,748 - Derynck , et al. June 26, 2 | 2018-06-26 |
Methods and compositions for modulating estrogen receptor mutants
Grant 9,855,270 - Hager , et al. January 2, 2 | 2018-01-02 |
Methods Of Treatment With Taselisib
App 20160375033 - Edgar; Kyle ; et al. | 2016-12-29 |
Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And A Cdk4/6 Inhibitor Compound For The Treatment Of Cancer
App 20160279142 - Friedman; Lori ; et al. | 2016-09-29 |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
Grant 9,335,320 - Ebens, Jr. , et al. May 10, 2 | 2016-05-10 |
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20160045515 - Belvin; Marcia ; et al. | 2016-02-18 |
Methods Of Treating Pr-positive, Luminal A Breast Cancer With Pi3k Inhibitor, Pictilisib
App 20150335650 - Derynck; Mika K. ; et al. | 2015-11-26 |
Therapeutic Combinations With Estrogen Receptor Modulators
App 20150258080 - Hager; Jeffrey J. ; et al. | 2015-09-17 |
Methods And Compositions For Modulating Estrogen Receptor Mutants
App 20150258099 - Hager; Jeffrey J. ; et al. | 2015-09-17 |
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
Grant 9,107,926 - Belvin , et al. August 18, 2 | 2015-08-18 |
SCDs as modifiers of the p53 pathway and methods of use
Grant 8,771,942 - Belvin , et al. July 8, 2 | 2014-07-08 |
Mutant Selectivity And Combinations Of A Phosphoinositide 3-kinase Inhibitor Compound And Chemotherapeutic Agents For The Treatment Of Cancer
App 20140044706 - Belvin; Marcia ; et al. | 2014-02-13 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20130345217 - Belvin; Marcia ; et al. | 2013-12-26 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents For The Treatment Of Hematopoietic Malignancies
App 20130330765 - Ebens, JR.; Allen J. ; et al. | 2013-12-12 |
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use
Grant 8,604,014 - Belvin , et al. December 10, 2 | 2013-12-10 |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
Grant 8,536,161 - Ebens, Jr. , et al. September 17, 2 | 2013-09-17 |
RORS as modifiers of the p21 pathway and methods of use
Grant 8,426,147 - Francis-Lang , et al. April 23, 2 | 2013-04-23 |
MAP3Ks as modifiers of the p53 pathway and methods of use
Grant 8,268,548 - Friedman , et al. September 18, 2 | 2012-09-18 |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
Grant 8,247,397 - Belvin , et al. August 21, 2 | 2012-08-21 |
Marks as modifiers of the p53 pathway and methods of use
Grant 8,153,384 - Friedman , et al. April 10, 2 | 2012-04-10 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20110223619 - Belvin; Marcia ; et al. | 2011-09-15 |
HPRP4s modifiers of the p53 pathway and methods of use
Grant 7,993,829 - Friedman , et al. August 9, 2 | 2011-08-09 |
GFATS as Modifiers of the P53 Pathway and Methods of Use
App 20110159508 - Friedman; Lori ; et al. | 2011-06-30 |
C20ORF23 as modifier of the IGFR pathway and methods of use
Grant 7,943,302 - Friedman , et al. May 17, 2 | 2011-05-17 |
Combinations Of A Pi3k Inhibitor And A Mek Inhibitor
App 20110086837 - Belvin; Marcia ; et al. | 2011-04-14 |
PDEs as modifiers of the IGFR pathways and methods of use
Grant 7,888,047 - Friedman , et al. February 15, 2 | 2011-02-15 |
Marks as modifiers of the p53 pathway and methods of use
App 20100325743 - Friedman; Lori ; et al. | 2010-12-23 |
HADHs as Modifiers of the p21 Pathway and Methods of Use
App 20100275275 - Friedman; Lori ; et al. | 2010-10-28 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents For The Treatment Of Hematopoietic Malignancies
App 20100233164 - Ebens, JR.; Allen J. ; et al. | 2010-09-16 |
MAN2As as modifiers of the IGFR pathway and methods of use
Grant 7,785,805 - Friedman , et al. August 31, 2 | 2010-08-31 |
SCDs As Modifiers of the p53 Pathway and Methods of Use
App 20100159470 - Belvin; Marcia ; et al. | 2010-06-24 |
C20ORF23 as modifier of the IGFR pathway and methods of use
App 20090202563 - Friedman; Lori ; et al. | 2009-08-13 |
RORS as Modifiers of the p21 Pathway and Methods of Use
App 20090149413 - Francis-Lang; Helen ; et al. | 2009-06-11 |
Combinations Of Phosphoinositide 3-kinase Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
App 20090098135 - Belvin; Marcia ; et al. | 2009-04-16 |
MAP3Ks as modifiers of the p53 pathway and methods of use
App 20090068186 - Friedman; Lori ; et al. | 2009-03-12 |
Pdes As Modifiers Of The Igfr Pathways And Methods Of Use
App 20090013416 - Friedman; Lori ; et al. | 2009-01-08 |
MARKs as Modifiers of the p53 Pathway and Methods of Use
App 20080166709 - Friedman; Lori ; et al. | 2008-07-10 |
SCDs As Modifiers of the p53 Pathway and Methods of Use
App 20080102070 - Belvin; Marcia ; et al. | 2008-05-01 |
Itpks as Modifiers of the Igfr Pathway and Methods of Use
App 20070292349 - Friedman; Lori ; et al. | 2007-12-20 |
Sppls as Modifiers of the P53 Pathway and Methods of Use
App 20070286852 - Belvin; Marcia ; et al. | 2007-12-13 |
Man2as as Modifiers of the Igfr Pathway and Methods of Use
App 20070264268 - Friedman; Lori ; et al. | 2007-11-15 |
HPRP4s Modifiers of the p53 Pathway and Methods of Use
App 20070160539 - Friedman; Lori ; et al. | 2007-07-12 |
Sphks as modifiers of the p53 pathway and methods of use
App 20060252035 - Friedman; Lori ; et al. | 2006-11-09 |
LIMKs as modifiers of p53 pathway and methods of use
App 20060160764 - Friedman; Lori ; et al. | 2006-07-20 |
Gpcs as modifiers of the irrtk p21 pathways and methods of use
App 20060121041 - Friedman; Lori ; et al. | 2006-06-08 |
Gfats as modifiers of the p53 pathway and methods of use
App 20060121457 - Friedman; Lori ; et al. | 2006-06-08 |
PRMTs as modifiers of the p53 pathway and methods of use
Grant 7,049,088 - Friedman , et al. May 23, 2 | 2006-05-23 |
Rors as modifiers of the p21 pathway and methods of use
App 20060101530 - Francis-Lang; Helen ; et al. | 2006-05-11 |
Flj20647s as modifiers of the p21 pathway and methods of use
App 20060063710 - Francis-Lang; Helen ; et al. | 2006-03-23 |
PRMTs as modifiers of the p53 pathway and methods of use
App 20060024665 - Friedman; Lori ; et al. | 2006-02-02 |
Slc2as as modifiers of the p53 pathway and methods of use
App 20060024673 - Friedman; Lori ; et al. | 2006-02-02 |
RRP sequences and knockout mice and uses thereof
Grant 6,972,179 - Friedman , et al. December 6, 2 | 2005-12-06 |
Csnk1gs as modifiers of the p21 pathway and methods of use
App 20050251870 - Francis-Lang, Helen ; et al. | 2005-11-10 |
Map3ks as modifiers of the p53 pathway and methods of use
App 20050227228 - Friedman, Lori ; et al. | 2005-10-13 |
PRMTs as modifiers of the p53 pathway and methods of use
App 20050186566 - Friedman, Lori ; et al. | 2005-08-25 |
HADHs as modifiers of the p21 pathway and methods of use
App 20050186200 - Friedman, Lori ; et al. | 2005-08-25 |
HADHs as modifiers of the p21 pathway and methods of use
App 20050181481 - Friedman, Lori ; et al. | 2005-08-18 |
HADHs as modifiers of the p21 pathway and methods of use
Grant 6,927,022 - Friedman , et al. August 9, 2 | 2005-08-09 |
Chds as modifiers of the p53 pathway and methods of use
App 20050170344 - Friedman, Lori ; et al. | 2005-08-04 |
Human RRP sequences and methods of use
Grant 6,924,117 - Lioubin , et al. August 2, 2 | 2005-08-02 |
Dgks as modifiers of the p53 pathwha and methods of use
App 20050112568 - Friedman, Lori ; et al. | 2005-05-26 |
Insect p53 tumor suppressor genes and proteins
App 20040161827 - Buchman, Andrew Roy ; et al. | 2004-08-19 |
Insect p53 tumor suppressor genes and proteins
Grant 6,762,291 - Buchman , et al. July 13, 2 | 2004-07-13 |
PDPK1s as modifiers of the p53 pathway and methods of use
App 20030215849 - Belvin, Marcia ; et al. | 2003-11-20 |
MSRAs as modifiers of the p53 pathway and methods of use
App 20030165966 - Belvin, Marcia ; et al. | 2003-09-04 |
RRP sequences and knockout mice and uses thereof
App 20030165497 - Lioubin, Mario N. ; et al. | 2003-09-04 |
MARKs as modifiers of the p53 pathway and methods of use
App 20030165809 - Friedman, Lori ; et al. | 2003-09-04 |
IGs as modifiers of the p53 pathway and methods of use
App 20030087266 - Friedman, Lori ; et al. | 2003-05-08 |
CADs as modifiers of the p53 pathway and methods of use
App 20030036076 - Friedman, Lori ; et al. | 2003-02-20 |
P5CRs as modifiers of the p53 pathway and methods of use
App 20030036078 - Friedman, Lori ; et al. | 2003-02-20 |
HPRP4s as modifiers of the p53 pathway and methods of use
App 20030027230 - Friedman, Lori ; et al. | 2003-02-06 |
SLC7s as modifiers of the p53 pathway and methods of use
App 20030027188 - Friedman, Lori ; et al. | 2003-02-06 |
HADHs as modifiers of the p21 pathway and methods of use
App 20030022222 - Friedman, Lori ; et al. | 2003-01-30 |
ADSLs as modifiers of the p53 pathway and methods of use
App 20030022209 - Friedman, Lori ; et al. | 2003-01-30 |
PRMTs as modifiers of the p53 pathway and methods of use
App 20030017489 - Friedman, Lori ; et al. | 2003-01-23 |
HS2STs as modifiers of the p53 pathway and methods of use
App 20030013144 - Friedman, Lori ; et al. | 2003-01-16 |
PIBs as modifiers of the p53 pathway and methods of use
App 20020192695 - Friedman, Lori ; et al. | 2002-12-19 |
Human RRP sequences and methods of use
App 20020022029 - Lioubin, Mario N. ; et al. | 2002-02-21 |
Drosophila homologues of genes and proteins implicated in metabolism and methods of use
App 20020009751 - Seidel-Dugan, Cindy ; et al. | 2002-01-24 |
Genetic markers for breast, ovarian, and prostatic cancer
Grant 5,622,829 - King , et al. April 22, 1 | 1997-04-22 |
| 